David J. Bearss

4 Patents

• US123382612025

  Alvocidib Prodrugs Having Increased Bioavailability

  Sumitomo Pharma Oncology, Inc.

  0 cites
• US122757382025

  CDK9 Inhibitors

  Biolexis Therapeutics, Inc.

  0 cites
• US117938022023

  Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure

  Sumitomo Pharma Oncology, Inc.

  0 cites
• US117124332023

  Compositions Comprising PKM2 Modulators and Methods of Treatment Using the Same

  Sumitomo Pharma Oncology, Inc.

  0 cites